PHARMACEUTICAL FACILITY BUILT BY NNE NAMED BEST IN THE WORLD

Main Menu | News By Date | News By Supplier | News By Category | About Us

PHARMACEUTICAL FACILITY BUILT BY NNE NAMED BEST IN THE WORLD
27 April 2005 - NNE A/S

The Danish NovoSeven Facility has been given the '2005 Facility of the Year Award' by the foremost representatives of the pharmaceutical industry's international engineering society. The award ceremony took place on Wednesday, April 27 at Interphex, the world's largest and most comprehensive pharmaceutical conference in New York.

The 14,000 square metre NovoSeven facility in Hillerød, Denmark, was designed and constructed as a fast-track project by the life science engineering company, NNE, for the healthcare company Novo Nordisk. The facility houses production of NovoSeven, which is used for treatment of bleeding of inhibitor patients.

By breaking down the building process into modules, NNE was able to complete the NovoSeven production facility in only 18 months. Such fast-track implementation is critical to the pharmaceutical industry where it is essential to establish manufacturing capacity as soon as a product has been approved by the authorities.

According to ISPE, the International Society for Pharmaceutical Engineering, one the sponsors for the award, the winning facility was chosen among 28 outstanding pharmaceutical facilities from 5 continents.

The award is given to a pharmaceutical manufacturer with a facility project that demonstrates global leadership, one that showcases cutting edge engineering, innovative new technology, or advanced applications of existing technology.

Vice President Henrik Risborg from Novo Nordisk accepted the award and replied: 'We built the NovoSeven Facility to meet an urgent demand for a life saving drug, and therefore we wanted it to be built faster than previously seen for a facility of this magnitude and complexity. And last but not least we went for a facility characterised by simplicity and transparency to ensure a safe working environment for the employees.

We knew this was not an easy job. But NNE picked up the challenge and they turned the NovoSeven project into a living case study of modular design and engineering in order to accelerate the building process. By joint efforts we succeeded and ended up with the desired manufacturing facility, built in record time, and still appearing as an architectural gem. This 'Facility of the Year Award' is a great acknowledgement to everyone involved in the project. '

On the following press conference Hans Ole Voigt, President of NNE, commented: 'It is a great honour for NNE that the NovoSeven Facility has won this highly prestigious award. It confirms my notion that the facility is an important milestone not only for NNE but also for the pharmaceutical industry. Challenged on the aggressive delivery schedule, the facility prompted us to rethink conventional ways of designing and building pharmaceutical facilities. As a result we developed the NNE modular concept, which enabled us to hand over the flexible facility after a fast-tracked 18-month period.'

http://nne.dk/

About: NNE A/S
With more than 80 years of experience, the engineering company NNE is a leading supplier of systems, consultancy and engineering services to the international pharmaceutical and biotechnological industry.

Our competencies span all technical disciplines applying to engineering, construction, validation, start-up and optimisation, and reconstruction of facilities for product development and production plants, pilot plants and laboratories within the pharmaceutical and biotechnological field.

Our unmistakable, clear client focus, combined with a flexible and integrated organisation where engineers, architects and pharmacists work closely together, puts us in a position to deliver customised solutions, ranging from stand-alone services to turnkey plants - quickly and safely.

NNE operates at an international level. We have worked on and completed a large number of projects both in Denmark and the rest of Scandinavia, and we have constructed biotechnological and pharmaceutical production facilities in USA, China, Japan, Brazil, and France.

More News:
  • For April 2005
  • From NNE A/S
  • For Medical Equipment